Home › Posts tagged Nektar Therapeutics

Tag: Nektar Therapeutics

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Nektar Therapeutics(NKTR:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$19.99 (USD) 03/26/2021 Weighted Valuation$24.92 (USD) Overall RatingUndervalued by 24.7% Valuation Models Comparables: $24.92 (USD) Valuation Methods …

Nektar Therapeutics (NKTR:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Uncategorised

Fundamental Valuation Report Amarin Corp(AMRN:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$20.47 (USD) 28/02/2019 Weighted Valuation$37.42 (USD) Overall RatingUndervalued by 82.8% Valuation Models Analyst Consensus: $43.00 (USD) (in …

Amarin Corp (AMRN:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Uncategorised

Fundamental Valuation Report Bio-Techne(TECH:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$188.58 (USD) 05/02/2019 Weighted Valuation$175.00 (USD) Overall RatingOvervalued by 7.2% Valuation Models Analyst Consensus: $175.00 (USD) (in order …

Bio-Techne (TECH:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Uncategorised

Fundamental Valuation Report Bio-Techne(TECH:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$170.57 (USD) 05/11/2018 Weighted Valuation$157.47 (USD) Overall RatingOvervalued by 7.7% Valuation Models Analyst Consensus: $175.00 (USD) (in order …

Bio-Techne (TECH:NAS) Fundamental Valuation Report Read more »

Read More